Abstract
Hallucinogenic drugs have been inhaled, ingested, worshipped, and reviled since prehistory. With the purification and synthesis of bontanical preparations and the ensuing discovery of chemically unique agents, hope was raised regarding their therapeutic potential, but this hope has been clouded by an epidemic of abuse and an inventory of adverse effects. This review examines aspects of that controversy, including the history of hallucinogens, epidemiology of current hallucinogen abuse, the association of LSD use with prolonged psychoses and hallucinogen persisting perception disorder, and the efforts to demonstrate the drug's therapeutic efficacy. Human subject ramifications in hallucinogen experimentation are discussed. Future lines of research are suggested in human, animal, and tissue culture paradigms.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Supported by USPHS Grant RO1 DA07120-01A2.
Rights and permissions
About this article
Cite this article
Abraham, H., Aldridge, A. & Gogia, P. The Psychopharmacology of Hallucinogens. Neuropsychopharmacol 14, 285–298 (1996). https://doi.org/10.1016/0893-133X(95)00136-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(95)00136-2
Keywords
This article is cited by
-
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
Psychopharmacology (2022)
-
In search of traces of the mandrake myth: the historical, and ethnobotanical roots of its vernacular names
Journal of Ethnobiology and Ethnomedicine (2021)
-
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
European Journal of Clinical Pharmacology (2021)
-
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Psychopharmacology (2011)